Zeitschriftenartikel zum Thema „CD44 antigen“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "CD44 antigen" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Escribano, Luis, Alberto Orfao, Jesús Villarrubia, Beatriz Díaz-Agustín, Carlos Cerveró, Agustín Rios, José L. Velasco, Juana Ciudad, José L. Navarro und Jesús F. San Miguel. „Immunophenotypic Characterization of Human Bone Marrow Mast Cells. A Flow Cytometric Study of Normal and Pathological Bone Marrow Samples“. Analytical Cellular Pathology 16, Nr. 3 (1998): 151–59. http://dx.doi.org/10.1155/1998/341340.
Shirure, Venktesh S., Tiantian Liu, Luis F. Delgadillo, Chaz M. Cuckler, David F. J. Tees, Fabian Benencia, Douglas J. Goetz und Monica M. Burdick. „CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions“. American Journal of Physiology-Cell Physiology 308, Nr. 1 (01.01.2015): C68—C78. http://dx.doi.org/10.1152/ajpcell.00094.2014.
HERMIDA-GÓMEZ, TAMARA, ISAAC FUENTES-BOQUETE, MARIA JOSÉ GIMENO-LONGAS, EMMA MUIÑOS-LÓPEZ, SILVIA DÍAZ-PRADO, FRANCISCO JAVIER de TORO und FRANCISCO JAVIER BLANCO. „Quantification of Cells Expressing Mesenchymal Stem Cell Markers in Healthy and Osteoarthritic Synovial Membranes“. Journal of Rheumatology 38, Nr. 2 (15.11.2010): 339–49. http://dx.doi.org/10.3899/jrheum.100614.
Sallusto, F., und A. Lanzavecchia. „Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.“ Journal of Experimental Medicine 179, Nr. 4 (01.04.1994): 1109–18. http://dx.doi.org/10.1084/jem.179.4.1109.
Kansas, GS, MJ Muirhead und MO Dailey. „Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans“. Blood 76, Nr. 12 (15.12.1990): 2483–92. http://dx.doi.org/10.1182/blood.v76.12.2483.2483.
Kansas, GS, MJ Muirhead und MO Dailey. „Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans“. Blood 76, Nr. 12 (15.12.1990): 2483–92. http://dx.doi.org/10.1182/blood.v76.12.2483.bloodjournal76122483.
Parsons, SF, J. Jones, DJ Anstee, PA Judson, B. Gardner, E. Wiener, J. Poole, N. Illum und SN Wickramasinghe. „A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b- ), Co(a-b-)]“. Blood 83, Nr. 3 (01.02.1994): 860–68. http://dx.doi.org/10.1182/blood.v83.3.860.860.
Parsons, SF, J. Jones, DJ Anstee, PA Judson, B. Gardner, E. Wiener, J. Poole, N. Illum und SN Wickramasinghe. „A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b- ), Co(a-b-)]“. Blood 83, Nr. 3 (01.02.1994): 860–68. http://dx.doi.org/10.1182/blood.v83.3.860.bloodjournal833860.
Mancuso, Patrizia, Ines Martin Padura, Giuliana Gregato, Paola Marighetti, Angelica Calleri, Chiara Corsini, Giancarlo Pruneri, Visnu Lohsiriwat, Jean Yves Petit und Francesco Bertolini. „CD45-CD34+ Endothelial Progenitor Cells (EPCs) from Human Adipose Tissue Promote Tumor Growth and Metastases“. Blood 118, Nr. 21 (18.11.2011): 2208. http://dx.doi.org/10.1182/blood.v118.21.2208.2208.
Rappa, G., F. Anzanello und A. Lorico. „CD24 expression and breast cancer stem cell phenotype“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 11106. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11106.
Schuurhuis, Gerrit J., Rolf Wouters, Angèle Kelder, Arjo P. Rutten, Alexander N. Snel, Monique Terwijn, Paul Noordhuis, Sonja Zweegman und Gert J. Ossenkoppele. „Specificity of Markers of Leukemia Initiating Cells with a New Multiparameter Flow Cytometry Based Appraoch; Impact for Prognostic and Therapeutic Applications“. Blood 116, Nr. 21 (19.11.2010): 1834. http://dx.doi.org/10.1182/blood.v116.21.1834.1834.
Marlina, Marlina, Rizki Rahmadian, Armenia Armenia, Wahyu Widowati, Rizal Rizal, Hanna Sari Widya Kusuma, Satrio Haryo Benowo Wibowo, Wahyu Setia Widodo und Ika Adhani Sholihah. „Isolation, Characterization, Proliferation and Differentiation of Synovial Membrane-derived Mesenchymal Stem Cells (SM-MSCs) from Osteoarthritis Patients“. Molecular and Cellular Biomedical Sciences 4, Nr. 2 (01.07.2020): 76. http://dx.doi.org/10.21705/mcbs.v4i2.100.
Florian, Stefan, Karoline Sonneck, Alexander W. Hauswirth, Maria-Theresa Krauth, Wolfgang R. Sperr und Peter Valent. „Phenotyping of Neoplastic (CD34+/CD38−/CD123+) Stem Cells in Myeloid Malignancies Reveals Expression of Multiple Molecular Targets.“ Blood 106, Nr. 11 (16.11.2005): 1381. http://dx.doi.org/10.1182/blood.v106.11.1381.1381.
Vicente, A., A. Varas, R. S. Acedón, E. Jiminez, J. J. Mulqoz und A. G. Zapata. „Appearance and Maturation of T-Cell Subsets During Rat Thymus Ontogeny“. Developmental Immunology 5, Nr. 4 (1998): 319–31. http://dx.doi.org/10.1155/1998/24239.
Zhang, Bao Yue, Hui Xue Song, Tan Chen und Zhan Hui Wang. „A Microfluidic Platform for Multi-Antigen Immunofluorescence Assays“. Applied Mechanics and Materials 108 (Oktober 2011): 200–205. http://dx.doi.org/10.4028/www.scientific.net/amm.108.200.
Collado, Antonia, Antonia de Andres, Encarnación Cañadas, Francisco Ruiz-Cabello, Ovidio Gomez, Susana Pedrinaci und Federico Garrido. „Characterization of CD44 Antigen during Lymphoid Ontogeny“. Immunobiology 183, Nr. 1-2 (September 1991): 1–11. http://dx.doi.org/10.1016/s0171-2985(11)80181-6.
Camp, R. L., T. A. Kraus, M. L. Birkeland und E. Puré. „High levels of CD44 expression distinguish virgin from antigen-primed B cells.“ Journal of Experimental Medicine 173, Nr. 3 (01.03.1991): 763–66. http://dx.doi.org/10.1084/jem.173.3.763.
Griffioen, Arjan W., Marieke J. H. Coenen, Cora A. Damen, Sandra M. M. Hellwig, David H.J. van Weering, Wim Vooys, Geert H. Blijham und Gerard Groenewegen. „CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells“. Blood 90, Nr. 3 (01.08.1997): 1150–59. http://dx.doi.org/10.1182/blood.v90.3.1150.
Griffioen, Arjan W., Marieke J. H. Coenen, Cora A. Damen, Sandra M. M. Hellwig, David H.J. van Weering, Wim Vooys, Geert H. Blijham und Gerard Groenewegen. „CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells“. Blood 90, Nr. 3 (01.08.1997): 1150–59. http://dx.doi.org/10.1182/blood.v90.3.1150.1150_1150_1159.
Weiss, Johannes M., Jonathan Sleeman, Andreas C. Renkl, Henning Dittmar, Christian C. Termeer, Sabine Taxis, Norma Howells et al. „An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function“. Journal of Cell Biology 137, Nr. 5 (02.06.1997): 1137–47. http://dx.doi.org/10.1083/jcb.137.5.1137.
Milde, Kerstin F., Rodolfo Alejandro, Daniel H. Mintz und Ricardo L. Pastori. „Molecular cloning of the canine CD44 antigen cDNA“. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1218, Nr. 1 (Mai 1994): 112–14. http://dx.doi.org/10.1016/0167-4781(94)90111-2.
Dzudzilo, Madara, Regīna Kleina, Ingrīda Čēma, Anita Dabuzinskiene und Šimons Svirskis. „Expression and Localisation of CD44 Antigen as a Prognostic Factor of Oral Leukoplakia“. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 75, Nr. 2 (01.04.2021): 68–74. http://dx.doi.org/10.2478/prolas-2021-0012.
Cheung, Sarah K. C., Po-Kai Chuang, Han-Wen Huang, Wendy W. Hwang-Verslues, Candy Hsin-Hua Cho, Wen-Bin Yang, Chia-Ning Shen et al. „Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells“. Proceedings of the National Academy of Sciences 113, Nr. 4 (17.12.2015): 960–65. http://dx.doi.org/10.1073/pnas.1522602113.
Sperr, WR, HC Bankl, G. Mundigler, G. Klappacher, K. Grossschmidt, H. Agis, P. Simon, P. Laufer, M. Imhof und T. Radaszkiewicz. „The human cardiac mast cell: localization, isolation, phenotype, and functional characterization“. Blood 84, Nr. 11 (01.12.1994): 3876–84. http://dx.doi.org/10.1182/blood.v84.11.3876.bloodjournal84113876.
van der Voort, Robbert, Robert M. J. Keehnen, Esther A. Beuling, Marcel Spaargaren und Steven T. Pals. „Regulation of Cytokine Signaling by B Cell Antigen Receptor and Cd40-Controlled Expression of Heparan Sulfate Proteoglycans“. Journal of Experimental Medicine 192, Nr. 8 (09.10.2000): 1115–24. http://dx.doi.org/10.1084/jem.192.8.1115.
Oelschlaegel, Uta, Kirsten Poppe-Thiede, Kristina Hoelig, Martin Bornhaeuser, Gerhard Ehninger und Frank Kroschinsky. „Differences in the Expression of Adhesion Molecules and Mobilization Efficacy in Healthy Stem Cell Donors and Patients with Hematologic Malignancies.“ Blood 104, Nr. 11 (16.11.2004): 2879. http://dx.doi.org/10.1182/blood.v104.11.2879.2879.
Croft, M., D. D. Duncan und S. L. Swain. „Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements.“ Journal of Experimental Medicine 176, Nr. 5 (01.11.1992): 1431–37. http://dx.doi.org/10.1084/jem.176.5.1431.
Min, Yoo-Hong, Ji Yeon Kim, Hoi Kyung Jeung, Seung Tae Lee und June-Won Cheong. „Ligation of CD44 by A3D8 Monoclonal Antibody Induces Terminal Differentiation of THP-1 Leukemia Cells by Promoting Cross-Talk between Extracellular Signal-Regulated Kinase and Phosphoinositide-3 Kinase/Akt Signaling Pathway.“ Blood 104, Nr. 11 (16.11.2004): 4460. http://dx.doi.org/10.1182/blood.v104.11.4460.4460.
Jaggupilli, Appalaraju, und Eyad Elkord. „Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity“. Clinical and Developmental Immunology 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/708036.
Utama, Bobby Indra. „ISOLATION OF AMNIOTIC FLUID MESENCHYMAL STEM CELLS (AF-MSCs) OBTAINED FROM CAESAREAN SECTIONS“. JOURNAL OBGIN EMAS 2, Nr. 1 (28.11.2019): 1–9. http://dx.doi.org/10.25077/aogj.2.1.1-9.2018.
Ng, David P., und Brent Wood. „Unsupervised Discovery of Early Markers of Erythroid Maturation in Human Donor Marrow“. Blood 124, Nr. 21 (06.12.2014): 4304. http://dx.doi.org/10.1182/blood.v124.21.4304.4304.
Brown, T. A., T. Bouchard, T. St John, E. Wayner und W. G. Carter. „Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.“ Journal of Cell Biology 113, Nr. 1 (01.04.1991): 207–21. http://dx.doi.org/10.1083/jcb.113.1.207.
Lai, Xiaoyu, He Huang, Li Huang und Fenfang Zeng. „Isolation of Human Bone Marrow Mesenchymal Stem Cells by a Novel Monoclonal Antibody, ZUC3.“ Blood 108, Nr. 11 (16.11.2006): 2562. http://dx.doi.org/10.1182/blood.v108.11.2562.2562.
Cizkova, Katerina, Jakub Malohlava und Zdenek Tauber. „Cell Membrane Nanostructure is Altered by Heat-Induced Antigen Retrieval: A Possible Consequence for Immunocytochemical Detection of Membranous Antigens“. Microscopy and Microanalysis 26, Nr. 1 (14.11.2019): 139–47. http://dx.doi.org/10.1017/s1431927619015113.
Camp, R. L., A. Scheynius, C. Johansson und E. Puré. „CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation.“ Journal of Experimental Medicine 178, Nr. 2 (01.08.1993): 497–507. http://dx.doi.org/10.1084/jem.178.2.497.
Romeijn, P., R. Lenthall, D. Stavrou, D. Melcher, H. Ladyman und MA Ritter. „Identification of glioma-associated antigen MUC 2-63 as CD44“. British Journal of Cancer 70, Nr. 5 (November 1994): 799–803. http://dx.doi.org/10.1038/bjc.1994.402.
Utama, Bobby Indra. „ISOLATION OF AMNIOTIC FLUID MESENCHYMAL STEM CELLS (AF-MSCs) OBTAINED FROM CAESAREAN SECTIONS“. JOURNAL OBGIN EMAS 2, Nr. 1 (28.11.2019): 1–9. http://dx.doi.org/10.25077/aoj.2.1.1-9.2018.
Maltzman, J. S., J. A. Carman und J. G. Monroe. „Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes.“ Molecular and Cellular Biology 16, Nr. 5 (Mai 1996): 2283–94. http://dx.doi.org/10.1128/mcb.16.5.2283.
Huang, Tzuu-Yuan, Jun-ichi Kuratsu, Hideo Takeshima, Toru Nishi und Yukitaka Ushio. „Expression of CD44 adhesion molecules in intracranial germinomas“. Neurosurgical Focus 5, Nr. 1 (Juli 1998): E5. http://dx.doi.org/10.3171/foc.1998.5.1.6.
McKinney-Freeman, Shannon L., Olaia Naveiras, Frank Yates, Sabine Loewer, Marsha Philitas, Matthew Curran, Peter J. Park und George Q. Daley. „Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells“. Blood 114, Nr. 2 (09.07.2009): 268–78. http://dx.doi.org/10.1182/blood-2008-12-193888.
Kube, D., M. Vockerodt, O. Weber, K. Hell, J. Wolf, B. Haier, F. A. Grässer et al. „Expression of Epstein-Barr Virus Nuclear Antigen 1 Is Associated with Enhanced Expression of CD25 in the Hodgkin Cell Line L428“. Journal of Virology 73, Nr. 2 (01.02.1999): 1630–36. http://dx.doi.org/10.1128/jvi.73.2.1630-1636.1999.
Koopman, G., K. H. Heider, E. Horst, G. R. Adolf, F. van den Berg, H. Ponta, P. Herrlich und S. T. Pals. „Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.“ Journal of Experimental Medicine 177, Nr. 4 (01.04.1993): 897–904. http://dx.doi.org/10.1084/jem.177.4.897.
Stanomir, Alina, Carmen Mihaela Mihu, Simona Rednic, Cristina Pamfil, Alexandra Roman, Andrada Soancă, Iulia Cristina Micu et al. „Oral Mesenchymal Stromal Cells in Systemic Sclerosis: Characterization and Response to a Hyaluronic-Acid-Based Biomaterial“. Applied Sciences 11, Nr. 17 (31.08.2021): 8101. http://dx.doi.org/10.3390/app11178101.
Sun, Wanling, Yongji Wu, Hui Li, Xuan Wang, Nong Zou und Junling Zhuang. „Establishment and Characterization of a New Human Myeloma Cell Line WuS1.“ Blood 106, Nr. 11 (16.11.2005): 5114. http://dx.doi.org/10.1182/blood.v106.11.5114.5114.
Morimoto, K., E. Robin, MC Le Bousse-Kerdiles, Y. Li, D. Clay, C. Jasmin und F. Smadja- Joffe. „CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells“. Blood 83, Nr. 3 (01.02.1994): 657–62. http://dx.doi.org/10.1182/blood.v83.3.657.657.
Morimoto, K., E. Robin, MC Le Bousse-Kerdiles, Y. Li, D. Clay, C. Jasmin und F. Smadja- Joffe. „CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells“. Blood 83, Nr. 3 (01.02.1994): 657–62. http://dx.doi.org/10.1182/blood.v83.3.657.bloodjournal833657.
Dallas, Matthew R., Guosheng Liu, Wei‐Chiang Chen, Susan N. Thomas, Denis Wirtz, David L. Huso und Konstantinos Konstantopoulos. „Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis“. FASEB Journal 26, Nr. 6 (13.03.2012): 2648–56. http://dx.doi.org/10.1096/fj.12-203786.
Migliaccio, Anna Rita F., Valentina Tirelli, Francesca Masiello, Massimo Sanchez, Carolyn Whitsett und Giovanni Migliaccio. „High Levels of CD44 Expression Identify Hematopoietic Cells Capable of Generating Great Numbers of Erythroid Cells Under HEMA Conditions“. Blood 116, Nr. 21 (19.11.2010): 3349. http://dx.doi.org/10.1182/blood.v116.21.3349.3349.
Leone, Julieta, Juan E. Perez, Maria E. Dominguez, Julian Iturbe, José P. Leone, Maria C. Mac Donnell, Gabriel Grosman, Carlos T. Vallejo, Bernardo A. Leone und Ariel O. Zwenger. „Role of Difucosylated Lewis Y Antigen in Outcome of Locally Advanced Cervical Squamous Cell Carcinoma Treated with Cisplatin Regimen“. International Journal of Biological Markers 31, Nr. 3 (Juli 2016): 300–308. http://dx.doi.org/10.5301/jbm.5000206.
Jalkanen, S., und M. Jalkanen. „Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.“ Journal of Cell Biology 116, Nr. 3 (01.02.1992): 817–25. http://dx.doi.org/10.1083/jcb.116.3.817.